Authors
Loading...
Systematic review reports 35% prevalence of fluoroquinolone resistance in Gram-negative bacteria, highlighting key risk factors.
Anggriawan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: